The physiologic basis for the pharmacologic use of recombinant erythropoietin

J. L. Spivak

doi:10.1177/107327489800502s05

The physiologic basis for the pharmacologic use of recombinant erythropoietin

J. L. Spivak

School of Medicine

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

While many growth factors influence erythroid progenitor cell proliferation, the hematopoietic growth factor erythropoietin has the most impact on the production of erythrocytes.

Original language	English (US)
Pages (from-to)	22-25
Number of pages	4
Journal	Cancer Control
Volume	5
Issue number	2 SUPPL.
DOIs	https://doi.org/10.1177/107327489800502s05
State	Published - 1998

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1177/107327489800502s05

Cite this

@article{f0df4df4206c43c18ed72a20b9181572,

title = "The physiologic basis for the pharmacologic use of recombinant erythropoietin",

abstract = "While many growth factors influence erythroid progenitor cell proliferation, the hematopoietic growth factor erythropoietin has the most impact on the production of erythrocytes.",

author = "Spivak, {J. L.}",

year = "1998",

doi = "10.1177/107327489800502s05",

language = "English (US)",

volume = "5",

pages = "22--25",

journal = "Cancer Control",

issn = "1073-2748",

publisher = "H. Lee Moffitt Cancer Center and Research Institute",

number = "2 SUPPL.",

}

TY - JOUR

T1 - The physiologic basis for the pharmacologic use of recombinant erythropoietin

AU - Spivak, J. L.

PY - 1998

Y1 - 1998

N2 - While many growth factors influence erythroid progenitor cell proliferation, the hematopoietic growth factor erythropoietin has the most impact on the production of erythrocytes.

AB - While many growth factors influence erythroid progenitor cell proliferation, the hematopoietic growth factor erythropoietin has the most impact on the production of erythrocytes.

UR - http://www.scopus.com/inward/record.url?scp=0031967528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031967528&partnerID=8YFLogxK

U2 - 10.1177/107327489800502s05

DO - 10.1177/107327489800502s05

M3 - Review article

AN - SCOPUS:0031967528

SN - 1073-2748

VL - 5

SP - 22

EP - 25

JO - Cancer Control

JF - Cancer Control

IS - 2 SUPPL.

ER -

The physiologic basis for the pharmacologic use of recombinant erythropoietin

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this